{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:41:27Z","timestamp":1792100487394,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yunnan Science and Technology Department and Kunming Medical University Special Fund","award":["Grant No. 202001AY070001-148"],"award-info":[{"award-number":["Grant No. 202001AY070001-148"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82060464"],"award-info":[{"award-number":["No.82060464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pelvic lymph node dissection (PLND) is commonly performed alongside radical prostatectomy. Its primary objective is to determine the lymphatic staging of prostate tumors by removing lymph nodes involved in lymphatic drainage. This aids in guiding subsequent treatment and removing metastatic foci, potentially offering significant therapeutic benefits. Despite varying recommendations from clinical practice guidelines across countries, the actual implementation of PLND is inconsistent, partly due to debates over its therapeutic value. While high-quality evidence supporting the superiority of PLND in oncological outcomes is lacking, its role in increasing surgical time and risk of complications is well-recognized. Despite these concerns, PLND remains the gold standard for lymph node staging in prostate cancer, providing invaluable staging information unattainable by other techniques. This article reviews PLND's scope, guideline perspectives, implementation status, oncologic and non-oncologic outcomes, alternatives, and future research needs.<\/jats:p>","DOI":"10.1186\/s12957-024-03344-2","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T03:01:57Z","timestamp":1708916517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review"],"prefix":"10.1186","volume":"22","author":[{"given":"Baonan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"1","key":"3344_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1148\/rg.311105072","volume":"31","author":"B Pa\u00f1o","year":"2011","unstructured":"Pa\u00f1o B, Sebasti\u00e0 C, Bu\u00f1esch L, et al. Pathways of Lymphatic Spread in Male Urogenital Pelvic Malignancies. Radiographics. 2011;31(1):135\u201360. https:\/\/doi.org\/10.1148\/rg.311105072.","journal-title":"Radiographics"},{"issue":"3","key":"3344_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.eururo.2012.06.057","volume":"63","author":"S Joniau","year":"2013","unstructured":"Joniau S, Van Den Bergh L, Lerut E, et al. Mapping of Pelvic Lymph Node Metastases in Prostate Cancer. Eur Urol. 2013;63(3):450\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2012.06.057.","journal-title":"Eur Urol"},{"key":"3344_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fsurg.2018.00052","volume":"5","author":"M Roscigno","year":"2018","unstructured":"Roscigno M, Nicolai M, La Croce G, et al. Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection. Front Surg. 2018;5:52. https:\/\/doi.org\/10.3389\/fsurg.2018.00052.","journal-title":"Front Surg"},{"issue":"7\u20138","key":"3344_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/ans.13872","volume":"87","author":"P Lee","year":"2017","unstructured":"Lee P, Francis KE, Solomon MJ, Ramsey-Stewart G, Austin KKS, Koh C. Triangle of Marcille: the anatomical gateway to lateral pelvic exenteration. ANZ J Surg. 2017;87(7\u20138):582\u20136. https:\/\/doi.org\/10.1111\/ans.13872.","journal-title":"ANZ J Surg"},{"issue":"1","key":"3344_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000500330","volume":"103","author":"AB Porcaro","year":"2019","unstructured":"Porcaro AB, Cacciamani GE, Sebben M, et al. Lymph Nodes Invasion of Marcille\u2019s Fossa Associates with High Metastatic Load in Prostate Cancer Patients Undergoing Extended Pelvic Lymph Node Dissection: The Role of \u201cMarcillectomy.\u201d Urol Int. 2019;103(1):25\u201332. https:\/\/doi.org\/10.1159\/000500330.","journal-title":"Urol Int"},{"issue":"10","key":"3344_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/pros.23987","volume":"80","author":"M Sebben","year":"2020","unstructured":"Sebben M, Tafuri A, Porcaro AB, Artibani W, Cacciamani G. Response to: Bando et al. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histological and molecular analyses. Prostate. 2020;80(10):795\u20136. https:\/\/doi.org\/10.1002\/pros.23987.","journal-title":"Prostate."},{"issue":"6","key":"3344_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/pros.23486","volume":"78","author":"J Miki","year":"2018","unstructured":"Miki J, Yanagisawa T, Tsuzuki S, et al. Anatomical localization and clinical impact of sentinel lymph nodes based on patterns of pelvic lymphatic drainage in clinically localized prostate cancer. Prostate. 2018;78(6):419\u201325. https:\/\/doi.org\/10.1002\/pros.23486.","journal-title":"Prostate"},{"issue":"8","key":"3344_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11255-018-1903-0","volume":"50","author":"M Stan\u00edk","year":"2018","unstructured":"Stan\u00edk M, Mac\u00edk D, \u010cap\u00e1k I, Mare\u010dkov\u00e1 N, L\u017e\u00ed\u010da\u0159ov\u00e1 E, Dole\u017eel J. Sentinel lymph node dissection in prostate cancer using superparamagnetic particles of iron oxide: early clinical experience. Int Urol Nephrol. 2018;50(8):1427\u201333. https:\/\/doi.org\/10.1007\/s11255-018-1903-0.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3344_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/S1677-5538.IBJU.2020.1063","volume":"48","author":"L Haiquel","year":"2022","unstructured":"Haiquel L, Cathelineau X, Sanchez-Salas R, Macek P, Secin F. Pelvic lymph node dissection in high-risk prostate cancer. Int Braz J Urol Off J Braz Soc Urol. 2022;48(1):54\u201366. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2020.1063.","journal-title":"Int Braz J Urol Off J Braz Soc Urol"},{"issue":"1","key":"3344_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","volume":"72","author":"N Fossati","year":"2017","unstructured":"Fossati N, Willemse PPM, Van den Broeck T, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017;72(1):84\u2013109. https:\/\/doi.org\/10.1016\/j.eururo.2016.12.003.","journal-title":"Eur Urol"},{"issue":"1","key":"3344_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eururo.2013.03.057","volume":"65","author":"G Ploussard","year":"2014","unstructured":"Ploussard G, Briganti A, De La Taille A, et al. Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications\u2014A Systematic Review of the Literature. Eur Urol. 2014;65(1):7\u201316. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.057.","journal-title":"Eur Urol"},{"issue":"1","key":"3344_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","volume":"65","author":"KA Touijer","year":"2014","unstructured":"Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy. Eur Urol. 2014;65(1):20\u20135. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.053.","journal-title":"Eur Urol"},{"key":"3344_CR13","doi-asserted-by":"publisher","unstructured":"Banapour P, Schumacher A, Lin JC, Finley DS. Radical Prostatectomy and Pelvic Lymph Node Dissection in Kaiser Permanente Southern California: 15-Year Experience. Perm J. 2019;23(1):17\u2013233.\u00a0https:\/\/doi.org\/10.7812\/TPP\/17-233.","DOI":"10.7812\/TPP\/17-233"},{"issue":"2","key":"3344_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, Van Den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243\u201362. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042.","journal-title":"Eur Urol."},{"issue":"1","key":"3344_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JU.0000000000002758","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. J Urol. 2022;208(1):19\u201325. https:\/\/doi.org\/10.1097\/JU.0000000000002758.","journal-title":"J Urol"},{"issue":"10","key":"3344_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN. 2023;21(10):1067\u201396. https:\/\/doi.org\/10.6004\/jnccn.2023.0050.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"key":"3344_CR17","volume-title":"Perioperative and oncological outcomes of radical prostatectomy for high\u2010risk prostate cancer in the UK: an analysis of surgeon\u2010reported data","author":"JJ Aning","year":"2019","unstructured":"Aning JJ, Reilly GS, Fowler S, Challacombe B, McGrath JS, Sooriakumaran P. Perioperative and oncological outcomes of radical prostatectomy for high\u2010risk prostate cancer in the UK: an analysis of surgeon\u2010reported data. 2019."},{"issue":"6","key":"3344_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00345-018-2195-9","volume":"36","author":"A Borkowetz","year":"2018","unstructured":"On behalf of the GeSRU Academics Prostate Cancer Group, Borkowetz A, Bruendl J, et al. Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer. World J Urol. 2018;36(6):855\u201361. https:\/\/doi.org\/10.1007\/s00345-018-2195-9.","journal-title":"World J Urol."},{"key":"3344_CR19","doi-asserted-by":"publisher","unstructured":"Leyh-Bannurah SR, Bud\u00e4us L, Zaffuto E, et al. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D\u2019Amico lymph node invasion risk stratification. Urol Oncol Semin Orig Investig. 2018;36(2):81.e17\u201324.\u00a0https:\/\/doi.org\/10.1016\/j.urolonc.2017.10.022.","DOI":"10.1016\/j.urolonc.2017.10.022"},{"key":"3344_CR20","doi-asserted-by":"publisher","unstructured":"Preisser F, Nazzani S, Bandini M, et al. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection. Urol Oncol Semin Orig Investig. 2018;36(8):365.e1\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.urolonc.2018.05.019.","DOI":"10.1016\/j.urolonc.2018.05.019"},{"key":"3344_CR21","doi-asserted-by":"publisher","unstructured":"Badani KK, Reddy BN, Moskowitz EJ, et al. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease. Urol Oncol Semin Orig Investig. 2018;36(6):310.e1\u20136.\u00a0https:\/\/doi.org\/10.1016\/j.urolonc.2018.03.004.","DOI":"10.1016\/j.urolonc.2018.03.004"},{"issue":"2","key":"3344_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/JU.0000000000000504","volume":"203","author":"F Preisser","year":"2020","unstructured":"Preisser F, van den Bergh RCN, Gandaglia G, et al. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D\u2019Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study. J Urol. 2020;203(2):338\u201343. https:\/\/doi.org\/10.1097\/JU.0000000000000504.","journal-title":"J Urol"},{"key":"3344_CR23","volume-title":"Re: Effects of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D\u2019Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Study","author":"A Skolarikos","year":"2019","unstructured":"Skolarikos A. Re: Effects of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D\u2019Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Study. 2019."},{"key":"3344_CR24","doi-asserted-by":"publisher","unstructured":"Tomisaki I, Ikuta H, Higashijima K, Onishi R, Minato A, Fujimoto N. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution. Cancer Invest. 2019;37(10):524\u201330.\u00a0https:\/\/doi.org\/10.1080\/07357907.2019.1675076.","DOI":"10.1080\/07357907.2019.1675076"},{"key":"3344_CR25","doi-asserted-by":"publisher","unstructured":"Kodiyan J, Guirguis A, Ashamalla H. Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival. Clin Genitourin Cancer. 2020;18(5):395\u2013401.e8.\u00a0https:\/\/doi.org\/10.1016\/j.clgc.2020.03.008.","DOI":"10.1016\/j.clgc.2020.03.008"},{"issue":"6","key":"3344_CR26","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bju.15034","volume":"125","author":"A Sood","year":"2020","unstructured":"Sood A, Keeley J, Palma-Zamora I, et al. Extended pelvic lymph-node dissection is independently associated with improved overall survival in patients with prostate cancer at high-risk of lymph-node invasion. BJU Int. 2020;125(6):756\u20138. https:\/\/doi.org\/10.1111\/bju.15034.","journal-title":"BJU Int"},{"issue":"5","key":"3344_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP, Guglielmetti GB, Trinh QD, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. 2021;79(5):595\u2013604. https:\/\/doi.org\/10.1016\/j.eururo.2020.11.040.","journal-title":"Eur Urol"},{"key":"3344_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP. Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi\u2019s Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. 2021;79:595\u2013604 Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. Eur Urol. Published online 2021.","journal-title":"Eur Urol"},{"issue":"4","key":"3344_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","volume":"4","author":"KA Touijer","year":"2021","unstructured":"Touijer KA, Sjoberg DD, Benfante N, et al. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. 2021;4(4):532\u20139. https:\/\/doi.org\/10.1016\/j.euo.2021.03.006.","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"3344_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/pros.24105","volume":"81","author":"MS Wettstein","year":"2021","unstructured":"Wettstein MS, David LA, Pazhepurackel C, et al. Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis. Prostate. 2021;81(5):286\u201394. https:\/\/doi.org\/10.1002\/pros.24105.","journal-title":"Prostate"},{"key":"3344_CR31","doi-asserted-by":"publisher","unstructured":"Preisser F, Bandini M, Marchioni M, et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. Prostate. 2018;78(6):469\u201375.\u00a0https:\/\/doi.org\/10.1002\/pros.23491.","DOI":"10.1002\/pros.23491"},{"issue":"1","key":"3344_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0090-4295(00)00550-1","volume":"56","author":"A Fergany","year":"2000","unstructured":"Fergany A, Kupelian PA, Levin HS, Zippe CD, Reddy C, Klein EA. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. Urology. 2000;56(1):92\u20135. https:\/\/doi.org\/10.1016\/S0090-4295(00)00550-1.","journal-title":"Urology"},{"issue":"2","key":"3344_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3892\/mco.2019.1965","volume":"12","author":"N Furubayashi","year":"2020","unstructured":"Furubayashi N, Negishi T, Uozumi T, et al. Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer. Mol Clin Oncol. 2020;12(2):104\u201310. https:\/\/doi.org\/10.3892\/mco.2019.1965.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"3344_CR34","doi-asserted-by":"publisher","first-page":"9675","DOI":"10.1038\/s41598-022-13651-x","volume":"12","author":"H Iwamura","year":"2022","unstructured":"Iwamura H, Hatakeyama S, Narita T, et al. Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy. Sci Rep. 2022;12(1):9675. https:\/\/doi.org\/10.1038\/s41598-022-13651-x.","journal-title":"Sci Rep"},{"key":"3344_CR35","doi-asserted-by":"publisher","unstructured":"Namiki S, Kawase M, Ebara S, et al. Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group). Cancers. 2022;14(23). https:\/\/doi.org\/10.3390\/cancers14235803.","DOI":"10.3390\/cancers14235803"},{"issue":"6","key":"3344_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.eururo.2009.03.012","volume":"55","author":"A Briganti","year":"2009","unstructured":"Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009;55(6):1251\u201365. https:\/\/doi.org\/10.1016\/j.eururo.2009.03.012.","journal-title":"Eur Urol"},{"key":"3344_CR37","doi-asserted-by":"publisher","unstructured":"Keegan, K.A., Cookson, M.S. Complications of Pelvic Lymph Node Dissection for Prostate Cancer. Curr Urol Rep. 2011;12:203\u20138. https:\/\/doi.org\/10.1007\/s11934-011-0179-z.","DOI":"10.1007\/s11934-011-0179-z"},{"issue":"2","key":"3344_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani GE, Maas M, Nassiri N, et al. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis. Eur Urol Oncol. 2021;4(2):134\u201349. https:\/\/doi.org\/10.1016\/j.euo.2021.02.001.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"3344_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000512960","volume":"106","author":"S Deutsch","year":"2022","unstructured":"Deutsch S, Hadaschik B, Lebentrau S, Ubrig B, Burger M, May M. Clinical Importance of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-Analysis. Urol Int. 2022;106(1):28\u201334. https:\/\/doi.org\/10.1159\/000512960.","journal-title":"Urol Int"},{"issue":"1","key":"3344_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","volume":"72","author":"N Fossati","year":"2017","unstructured":"Fossati N, Willemse PPM, Van den Broeck T, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017;72(1):84\u2013109. https:\/\/doi.org\/10.1016\/j.eururo.2016.12.003.","journal-title":"Eur Urol"},{"key":"3344_CR41","doi-asserted-by":"publisher","unstructured":"Go\u00dfler C, May M, Breyer J, Stojanoski G, Weikert S, Lenart S, et al. High BMI, Aggressive Tumours and Long Console Time Are Independent Predictive Factors for Symptomatic Lymphocele Formation after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection. Urol Int. 2021;105(5-6):453\u20139. https:\/\/doi.org\/10.1159\/000514439.","DOI":"10.1159\/000514439"},{"key":"3344_CR42","doi-asserted-by":"publisher","unstructured":"Sforza S, Tellini R, Grosso AA, et al. Can we predict the development of symptomatic lymphocele following robot-assisted radical prostatectomy and lymph node dissection? Results from a tertiary referral Centre. Scand J Urol. 2020;54(4):328\u201333.\u00a0https:\/\/doi.org\/10.1080\/21681805.2020.1784270.","DOI":"10.1080\/21681805.2020.1784270"},{"key":"3344_CR43","doi-asserted-by":"publisher","unstructured":"Porcaro AB, Sebben M, Tafuri A, et al. Body mass index is an independent predictor of Clavien\u2013Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection. J Robot Surg. 2019;13(1):83\u20139.\u00a0https:\/\/doi.org\/10.1007\/s11701-018-0824-3.","DOI":"10.1007\/s11701-018-0824-3"},{"key":"3344_CR44","doi-asserted-by":"publisher","unstructured":"Thomas C, Ziewers S, Thomas A, et al. Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis. Int Urol Nephrol. 2019;51:633\u201340. https:\/\/doi.org\/10.1007\/s11255-019-02103-7.","DOI":"10.1007\/s11255-019-02103-7"},{"key":"3344_CR45","doi-asserted-by":"publisher","unstructured":"Deutsch S, Hadaschik B, Lebentrau S, Ubrig B, Burger M, May M. Clinical Importance of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-Analysis. Urol Int. 2022;106(1):28\u201334. https:\/\/doi.org\/10.1159\/000512960.","DOI":"10.1159\/000512960"},{"key":"3344_CR46","volume-title":"Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study","author":"M Neuberger","year":"2021","unstructured":"Neuberger M. Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study. 2021."},{"key":"3344_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15497","volume-title":"Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection","author":"RM Pose","year":"2021","unstructured":"Pose RM, Knipper S, Wu C, Maurer T, Graefen M, Steuber T. Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection. 2021."},{"key":"3344_CR48","volume-title":"Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy","author":"JU Stolzenburg","year":"2018","unstructured":"Stolzenburg JU. Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy. 2018."},{"key":"3344_CR49","doi-asserted-by":"publisher","unstructured":"Motterle G, Morlacco A, Zanovello N, et al. Surgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic Review. J Endourol. 2020;34(2):113\u201320. https:\/\/doi.org\/10.1089\/end.2019.0716.","DOI":"10.1089\/end.2019.0716"},{"issue":"6","key":"3344_CR50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00270-019-02209-6","volume":"42","author":"HH Chu","year":"2019","unstructured":"Chu HH, Shin JH, Kim JW, Noh SY, Yang WJ, Park S. Lymphangiography and Lymphatic Embolization for the Management of Pelvic Lymphocele After Radical Prostatectomy in Prostatic Cancer. Cardiovasc Intervent Radiol. 2019;42(6):873\u20139. https:\/\/doi.org\/10.1007\/s00270-019-02209-6.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"3344_CR51","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00345-019-02965-7","volume":"38","author":"N Branger","year":"2020","unstructured":"Branger N, Pignot G, Lannes F, et al. Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy. World J Urol. 2020;38(7):1719\u201327. https:\/\/doi.org\/10.1007\/s00345-019-02965-7.","journal-title":"World J Urol"},{"key":"3344_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2018.04.016","volume-title":"External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients","author":"TA Hueting","year":"2018","unstructured":"Hueting TA. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. 2018."},{"key":"3344_CR53","volume-title":"A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals","author":"M Bandini","year":"2017","unstructured":"Bandini M. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. 2017."},{"issue":"5","key":"3344_CR54","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00345-020-03322-9","volume":"39","author":"N Peilleron","year":"2021","unstructured":"Peilleron N, Seigneurin A, Herault C, et al. External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients. World J Urol. 2021;39(5):1489\u201397. https:\/\/doi.org\/10.1007\/s00345-020-03322-9.","journal-title":"World J Urol"},{"key":"3344_CR55","doi-asserted-by":"publisher","unstructured":"Oderda M, Diamand R, Albisinni S, et al. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion. BJU Int. 2021;127(3):318\u201325.\u00a0https:\/\/doi.org\/10.1111\/bju.15220.","DOI":"10.1111\/bju.15220"},{"key":"3344_CR56","doi-asserted-by":"publisher","unstructured":"Sahin A, Urkmez A, Yildirim C, Ali Kutluhan M, Topakta\u015f R, Verit A. Sensitivity and specificity of Briganti nomogram in Turkish patients undergoing radical prostatectomy and pelvic lymph node dissection. Aging Male. 2020;23(5):836\u201340. https:\/\/doi.org\/10.1080\/13685538.2019.1601176.","DOI":"10.1080\/13685538.2019.1601176"},{"issue":"3","key":"3344_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00345-020-03227-7","volume":"39","author":"H Peabody","year":"2021","unstructured":"For the Michigan Urological Surgery Improvement Collaborative, Peabody H, Lane BR, et al. Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy. World J Urol. 2021;39(3):779\u201385. https:\/\/doi.org\/10.1007\/s00345-020-03227-7.","journal-title":"World J Urol."},{"issue":"5","key":"3344_CR58","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00330-017-5229-6","volume":"28","author":"G Brembilla","year":"2018","unstructured":"Brembilla G, Dell\u2019Oglio P, Stabile A, et al. Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection. Eur Radiol. 2018;28(5):1969\u201376. https:\/\/doi.org\/10.1007\/s00330-017-5229-6.","journal-title":"Eur Radiol"},{"key":"3344_CR59","volume-title":"A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies","author":"G Gandaglia","year":"2018","unstructured":"Gandaglia G. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. 2018."},{"key":"3344_CR60","doi-asserted-by":"crossref","unstructured":"Hatano K, Tanaka J, Nakai Y, et al. Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer. Jpn J Clin Oncol. 2019.","DOI":"10.1093\/jjco\/hyz170"},{"issue":"7","key":"3344_CR61","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1007\/s00261-021-02982-4","volume":"46","author":"B Hu","year":"2021","unstructured":"Hu B, Deng Y, Chen J, et al. Evaluation of MR elastography for prediction of lymph node metastasis in prostate cancer. Abdom Radiol. 2021;46(7):3387\u2013400. https:\/\/doi.org\/10.1007\/s00261-021-02982-4.","journal-title":"Abdom Radiol"},{"key":"3344_CR62","doi-asserted-by":"publisher","unstructured":"Huang C, Song G, Wang H, et al. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Prostate Cancer Prostatic Dis. 2020;23:116\u201326. https:\/\/doi.org\/10.1038\/s41391-019-0164-z.","DOI":"10.1038\/s41391-019-0164-z"},{"key":"3344_CR63","volume-title":"A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging","author":"ED Trapani","year":"2020","unstructured":"Trapani ED, Cordima G, Matei DV, Cobelli OD. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging. Urol Oncol: Published online; 2020."},{"key":"3344_CR64","unstructured":"Molecular and functional imaging for detection of lymph node metastases in prostate cancer - PubMed. \nhttps:\/\/pubmed.ncbi.nlm.nih.gov\/23823804\/. Accessed 8 Nov 2023."},{"issue":"4","key":"3344_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"G Gandaglia","year":"2022","unstructured":"Gandaglia G, Mazzone E, Stabile A, et al. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study. Eur Urol. 2022;82(4):411\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.002.","journal-title":"Eur Urol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03344-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:10:14Z","timestamp":1709244614000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3344"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03344-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}